BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14767272)

  • 1. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
    Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
    Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
    Filson CP; Schwartz K; Colt JS; Ruterbusch J; Linehan WM; Chow WH; Miller DC
    Urol Oncol; 2014 Jan; 32(1):27.e15-21. PubMed ID: 23419677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
    Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
    Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
    Wu XW; Zhou PP; Dong Q
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.
    Xu H; Xing Z; Ai K; Wang J; Lv Z; Deng H; Li K; Wang Y; Li Y
    World J Surg Oncol; 2024 Jan; 22(1):24. PubMed ID: 38254091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.
    Marchiñena PG; Tirapegui S; Gonzalez IT; Jurado A; Gueglio G
    Int Braz J Urol; 2018; 44(3):475-482. PubMed ID: 29368873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of partial versus radical nephrectomy for renal cell carcinoma: Is oncologic safety compromised during nephron sparing in higher stage disease?
    Hakam N; Heidar NA; El-Asmar J; Khauli M; Degheili J; Al-Moussawy M; Nasr R; El-Hajj A; Wazzan W; Bulbul M; Khauli RB
    Urol Ann; 2023; 15(2):226-231. PubMed ID: 37304513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redo nephron-sparing surgery in stage V pediatric renal tumors - A report from the SIOP/GPOH study group for renal tumors.
    Fuchs J; Schunn MC; Schäfer JF; Ebinger M; Graf N; Furtwängler R; Warmann SW
    Eur J Surg Oncol; 2024 Jan; 50(1):107265. PubMed ID: 38035461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary lesion after surgery for renal cancer: progression or new primary?
    Cignoli D; Bandiera A; Rosiello G; Castorina R; Re C; Cei F; Musso G; Belladelli F; Freschi M; Lucianò R; Raggi D; Negri G; Necchi A; Salonia A; Montorsi F; Larcher A; Capitanio U
    World J Urol; 2024 May; 42(1):361. PubMed ID: 38814376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and late kidney effects of nephron-sparing surgery in the management of unilateral Wilms tumor: a systematic review and meta-analysis.
    Li S; Wang J; Li M; Zhang Z; Mi T; Wu X; Wang Z; Jin L; He D
    Pediatr Surg Int; 2023 Dec; 40(1):29. PubMed ID: 38150145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological characteristics of renal cell carcinomas with MiTF translocation.
    Filler T; Verkarre V; Peyrottes A; Poinard F; Lupo A; Dariane C; Hurel S; Timsit MO; Mejean A; Audenet F
    Fr J Urol; 2024 Mar; 34(2):102569. PubMed ID: 38717457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database.
    Lim K; Riveros C; Ranganathan S; Xu J; Patel A; Slawin J; Ordonez A; Aghazadeh M; Morgan M; Miles BJ; Esnaola N; Klaassen Z; Allenson K; Brooks M; Wallis CJD; Satkunasivam R
    Urol Oncol; 2023 Apr; 41(4):209.e1-209.e9. PubMed ID: 36801191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.
    Hsu RCJ; Barclay M; Loughran MA; Lyratzopoulos G; Gnanapragasam VJ; Armitage JN
    BJU Int; 2018 Oct; 122(4):599-609. PubMed ID: 29603575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.
    Trevisani F; Ghidini M; Larcher A; Lampis A; Lote H; Manunta P; Alibrandi MT; Zagato L; Citterio L; Dell'Antonio G; Carenzi C; Capasso G; Rugge M; Rigotti P; Bertini R; Cascione L; Briganti A; Salonia A; Benigni F; Braconi C; Fassan M; Hahne JC; Montorsi F; Valeri N
    Br J Cancer; 2016 Nov; 115(11):1343-1350. PubMed ID: 27802451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrometry Scoring Systems for Nephron Sparing Surgery in Children.
    Mrad C; Chamouni A; Guerra X; Tordjman M; Tabone MD; Audry G; Irtan S
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):1-7. PubMed ID: 37962119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient.
    Sebastian W; Omar KO; Anees R; Nagaraju S; Chaitanya M
    Am J Case Rep; 2024 Mar; 25():e941214. PubMed ID: 38442088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Localized Renal Cell Carcinoma Across Different Races.
    So WZ; Fong KY; Wang Z; Tiong HY
    Clin Med Res; 2023 Sep; 21(3):122-128. PubMed ID: 37985170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.